Aptose Biosciences Inc.
(Toronto Stock Exchange : APTO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.51%190.581.2%$558.38m
GILDGilead Sciences, Inc.
-0.32%70.690.9%$494.14m
BIIBBiogen Inc.
-1.47%314.391.3%$441.96m
CELGCelgene Corporation
-0.80%69.681.2%$415.08m
ILMNIllumina, Inc.
-1.14%307.633.5%$393.75m
REGNRegeneron Pharmaceuticals, Inc.
-1.56%336.772.6%$277.39m
VRTXVertex Pharmaceuticals Incorporated
-3.79%163.851.9%$261.05m
ALXNAlexion Pharmaceuticals, Inc.
-1.86%116.322.0%$195.38m
AAgilent Technologies, Inc.
-1.14%63.611.5%$166.24m
EXASExact Sciences Corporation
-1.80%68.1625.3%$146.96m
LGNDLigand Pharmaceuticals Incorporated
-0.42%147.8023.3%$143.00m
SRPTSarepta Therapeutics, Inc.
-5.04%110.8916.4%$126.85m
ECYTEndocyte, Inc.
-0.04%23.572.0%$120.21m
INCYIncyte Corporation
-0.24%63.582.5%$112.13m
NKTRNektar Therapeutics
1.66%37.975.6%$107.61m

Company Profile

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.